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INTRODUCTION
Pharmacodynamic effects of drugs are often measured 
using time-domain series of physiological data, e.g., vascu-
lar reactivity, blood pressure, electrocardiograms, or elec-
troencephalograms. It is not uncommon that large amounts 
of data are reduced to but a few data points expressing, 
e.g., a drug effect at a certain dose. The dynamic compo-
nent and the effect of time are hereby lost. However, high-
resolution physiological data include potentially considerably 
more information about the biological system’s behavior, 
which can be relevant for assessing drug efficacy or safety. 
The purpose of this work was to develop a hypothesis-free 
mathematical algorithm, capable of predicting the dynamic 
behavior of time-dependent contractile reactivity of isolated 
blood vessels. An advantage of a hypothesis-free approach 
is that no assumptions are made with regard to the underly-
ing mechanism of the dynamic process. This is of importance 
in the development of new medicines for which understand-
ing of mechanisms of action, or in particular, potential off-
target effects of the new drug, may be incomplete. Vascular 
reactivity is central in normal physiology, as also in the etiol-
ogy of pathologies of the cardiovascular system. It serves as 
a surrogate end point for pharmacological treatment aimed 
toward normalization of altered vascular function. Classic 
pharmacological characterization of in vitro isolated blood 
vessels or mathematical modeling of blood vessels has clari-
fied molecular mechanisms1–3 and biophysical characteris-
tics controlling vascular smooth muscle contractile behavior.4 
However, these methods are often based on assumptions 
of steady state and simplifications of the underlying mecha-
nism. Principally, the dynamics of contractile behavior, an 
emergent property of blood vessels, is too complex to explain 
on the basis of a few parameters. Adaptation, feedback 
mechanisms, and structural remodeling, among others, may 
alter initial assumptions and can therefore not be accounted 
for by classic methods of investigation.5–7 For example, time-
domain data of force development in isolated blood vessels 
is reduced to a few extracted data points and analyzed in 
order to understand artery dynamics. Hence, most available 
data are discarded as nonuseful information. Although wave-
form analysis–fast Fourier transform has revealed the chaotic 
dynamic behavior of isolated blood vessels,8,9 the patterns of 
tension generated over time of specific isolated blood ves-
sels are often characteristic for the type and origin of arteries 
and may be indicative of underlying system changes due to 
pathology.10,11
Therefore, artificial intelligence or machine learning meth-
ods may help in describing dynamic patterns of system 
behavior by learning all information in the data. In mathemati-
cal modeling, ordinary differential equations could describe a 
mechanistic model of systems. However, these approaches 
are incapable of describing all parameters of the system 
or uncertainties due to changes in either the system or its 
parameters.4 To address this problem, fuzzy logic may be 
an alternative, providing rule-based modeling in which the 
phenotypic expression of the system is under control (i.e., 
tension), rather than its individual components. A fuzzy logic 
system is, by nature, capable of capturing the behavior and 
unexpected events of nonlinear complex dynamic systems 
within certain limits. It has been used previously in pharma-
cology for different purposes.12–15
This study describes the development of a genetic 
fuzzy system (GFS) as a method to study and predict the 
dynamic behavior of contractile responses of isolated arter-
ies. Briefly, GFS is an artificial intelligence–based com-
puter algorithm that can recognize patterns. GFS has two 
constituents, a genetic algorithm (GA), which is a search 
algorithm that is used to find the most optimal solution to a 
fuzzy logic system, which is the second component of the 
algorithm that enables prediction of dynamic behavior or 
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Monitoring of physiological surrogate end points in drug development generates dynamic time-domain data reflecting the state 
of the biological system. Conventional data analysis often reduces the information in these data by extracting specific data 
points, thereby discarding potentially useful information. We developed a genetic fuzzy system (GFS) algorithm that is capable 
of learning all information in time-domain physiological data. Data on isometric force development of isolated small arteries 
were used as a framework for developing and optimizing a GFS. GFS performance was improved by several strategies. Results 
show that optimized fuzzy systems (OFSs) predict contractile reactivity of arteries accurately. In addition, OFSs identified 
significant differences that were undetectable using conventional analysis in the responses of arteries between groups. We 
concluded that OFSs may be used in clustering or classification tasks as aids in the objective identification or prediction of 
dynamic physiological behavior.
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patterns. The principle behind GFS is to explore information 
from experimental data, in cases where there is only par-
tial or no mechanistic knowledge of the complex biological 
system.16,17
Thus, the purpose of this study is to optimize a fuzzy con-
trol system using a GA and to use the optimized fuzzy sys-
tem (OFS) to predict contractile reactivity data of arteries as 
accurately as possible. OFSs are thus shown to be superior 
to conventional analysis in identifying differences in vascular 
behavior.
ReSUlTS
This study comprised two parts: development of the GFS 
algorithm, and application of an OFS.
GFS development
The experimental data (data set 1) used for development of 
the GFS algorithm consisted of recordings of isometric force 
development in isolated resistance-sized branches of rat 
femoral arteries (Figure 1). In Figure 1, vertical lines rep-
resent additions of vasoactive compounds at various time 
points and at different concentrations. The nature of these 
compounds is, in principle, not relevant for the purpose of this 
study, but details of the experimental protocols are provided 
in the Supplementary Data.
GFS design and implementation. The GFS design had two 
objectives that would collectively improve GFS performance 
(i) to obtain an OFS yielding the best prediction for available 
data and (ii) to improve computational efficiency. A detailed 
description of the GFS principles is provided in the Supple-
mentary Data. Principally, a GA is used to optimize a fuzzy 
system that can predict the behavior of the dynamic response, 
based on a fitness value. The fitness value is defined as the 
difference between the output and the desired output, i.e., 
the cumulative sum of the squared errors and can be consid-
ered similar to goodness of fit (see Supplementary Data).
Variation in the number of membership functions per fuzzy 
set, from two (GFS (222)) to six (GFS (666)) for each of two 
Figure 1 Recordings of isometric tension development in isolated rat femoral arteries over time, expressed as normalized pressure. These 
data sets were used as training and test sets for genetic fuzzy system (GFS) development. Vertical lines represent additions of vasoactive 
substances in various concentrations (see Supplementary Data for complete experimental protocol). (a) Data set 1; (b) data set 2. Each 
panel displays recordings of four different arteries, represented by different colors.
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inputs and one output, showed no correlation with GFS per-
formance (Figure 2). Therefore, the simplest GFS design 
with two fuzzy sets per variable (GFS (222)) yielded the best 
computation-to-fitness ratio. Strategies were implemented 
to improve either the search heuristic for fuzzy systems or 
to improve performance. The results of these strategies are 
described below.
GFS performance. Briefly, four strategies were performed 
either singly or in combination affecting (i) type and weight 
of membership functions, (ii) generation of membership func-
tion variables, (iii) population strategy, and (iv) fuzzy system 
range and defuzzification method. The impact of these strate-
gies was assessed using system GFS(222). Figure 3a dis-
plays evolution of fitness over 1,000 generations using fuzzy 
sets with six possible membership functions as suggested 
by Shi et al.18 Repetition yielded comparable fitness values, 
indicating that searches ended in the same minimum. Imple-
menting strategies 1 and 2 by increasing the number of mem-
bership functions and how these were generated resulted in 
an evolution of fitness shown in Figure 3b,c. With these two 
strategies, the system becomes more flexible and adaptive to 
dynamic changes in data. Nevertheless, the same algorithm 
design resulted in different fitness values that were either 
similar (Figure 3a) or worse with strategy 1 alone. In addition, 
a large variation in mean fitness during the optimization pro-
cess indicated that this design not necessarily converge to a 
global minimum in just one run. Addition of strategy 3 to the 
algorithm design resulted in an evolution of fitness as shown 
in Figure 3d, suggesting that a combination of all three strat-
egies gave the largest diversity in the population, further 
improving the chance to obtain individuals with good fitness.
Figure 2 The impact of different numbers of fuzzy sets per input or 
output on optimized fuzzy system (OFS) fitness values. Displayed 
are best fitness values for different OFSs from OFS(222) containing 
any combination ranging from two fuzzy sets per input or output up 
to OFS(456) containing four and five fuzzy sets, or six fuzzy sets, for 
the two inputs and one output, respectively. There was no correlation 
with number of fuzzy sets and fitness values in OFSs.
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Figure 3 Different strategies were investigated in order to improve the genetic algorithm search for the most optimal fuzzy system. This figure 
depicts the evolution of fitness values over 1,000 generations of GFS(222) with these strategies. (a) GFS(222) evolution of fitness using 
fuzzy sets with six possible membership functions, as suggested by Shi et al.23 (final best fitness: 6,097.33; final mean fitness: 6,097.46; 
range: 6,097.30–6,102.20); (b,c) different runs of GFS(222) with strategies 1 plus 2; ((b) final best fitness: 3,071.02; final mean fitness: 
169,377; range: 3,071.00–1,760,600; (c) final best fitness: 6,708.43; final mean fitness: 34,097; range: 6,708.40–1,314,400); (d) GFS(222) with 
strategies 1, 2, and 3. The training data are from the nonnormalized data of BV1 (final best fitness: 2,979.78; final mean fitness: 399,836; range: 
2,979.80–3,397,800). Solid circles represent the best fitness at each generation, and open circles represent mean fitness per generation.
0
103
104
105
106F
itn
es
s 
va
lu
e
103
104
105
106
200 400 600 800 0
Generation
200 400 600 800 1,000
a b
c d
CPT: Pharmacometrics & Systems Pharmacology
Machine Learning of Physiological Responses
Tang et al.
4
Although strategies 1–3 improved the performance of the 
GFS dramatically, the prediction of OFSs appeared worst 
at the extremes of the data range (Figure 4a). Two possible 
reasons could be responsible for this. First, some member-
ship functions are rarely being used in fuzzy sets of the 
OFS at either ends of each input or output, e.g., Gaussian, 
triangle, or trapezoid-shaped functions (Supplementary 
Figures S1 and S2). Additionally, because the default 
defuzzification function in Matlab is centroid, the prediction 
at the borders of the output was underestimated. With strat-
egy 4, these drawbacks were overcome and predictions fur-
ther improved (Figure 4b).
OFS test and specificity. Prediction of data using OFS(222) 
of a small population of arteries is illustrated in Figure 5. It is 
evident that, by this method, the averaged prediction of the 
population of arteries can almost be superimposed on the 
averaged original data and variation in the prediction is well 
within that of the original data.
The difference in fitness between an OFS training artery 
and others using the same OFS reflects specificity. Speci-
ficity was investigated by increasing the number of inputs 
(see Supplementary Data) and by comparing fitness of 
these OFSs for recordings of arteries with the same (proto-
col 1) or different (protocol 2) experimental protocols. Four 
OFSs with different inputs were optimized using the same 
training data from blood vessel 3 (BV3) (Table 1). Absolute 
fitness values and the percentage difference between train-
ing data fitness and test data fitness are shown. The higher 
the percentage difference, the more specific the OFS is for 
predicting a certain data set. In general, the training artery 
had the best fitness with different OFSs. Additionally, for 
every increase in inputs, the fitness for arteries in proto-
col 1 was better than that for recordings in protocol 2. Fur-
thermore, it is evident that increasing the number of inputs 
improved OFS specificity because the difference in fitness for 
training artery and test data increased proportionally with 
more inputs.
Application of GFSs
Comparison of OFSs with conventional analysis of data 
was performed using another data set consisting of two 
experimental groups of isolated rat small mesenteric arter-
ies that had either been freshly isolated (Group A) or been 
incubated for 24 h in tissue culture medium (Group B). The 
dynamic pattern of norepinephrine cumulative concentra-
tion–response relationships in these arteries was visually 
very different between groups (Figure 6a). In the continu-
ous presence of increasing concentrations of norepineph-
rine, contractions in freshly isolated arteries were relatively 
stable, whereas in cultured arteries, contractions were tran-
sient and returned to baseline state, despite the presence 
of norepinephrine. Conventional analysis of norepineph-
rine potency and maximal responses, either as maximum 
response or as averaged responses per concentration, did 
not reveal this difference (Figure 6b). On the other hand, 
fitness values that were generated by an OFS, trained on a 
random artery of either Group A or Group B, revealed sta-
tistically significant differences between groups (Figure 6c). 
OFSs trained on either Group A or Group B showed differ-
ences in absolute fitness values and variance of fitness, illus-
trating (i) a larger variation in dynamic behavior of arteries in 
Group B as compared with that in Group A and (ii) greater 
specificity of OFSs trained on Group B data. Nevertheless, 
differences between groups were evident regardless of the 
training set. Fuzzy rules of these OFSs are provided in the 
Supplementary Table S1.
Figure 4 Representative part of original data from data set 1 
visualizing improvement in prediction at the bottom and top ranges 
of data with the addition of strategy 4. (a) Prediction using OFS(222) 
without strategy 4; (b) prediction using OFS(222) with strategy 4. 
The training data are from the normalized data of BV3 (black line), 
whereas the prediction is represented by the blue line.
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Figure 5 Test of optimized fuzzy system. The black solid line shows 
the averaged normalized pressure data trace of the population 
of blood vessels from data set 1, with standard error indicated 
by the dotted black lines. The average and standard error of the 
prediction of the population are shown as solid and dotted red 
lines, respectively. The prediction is not always visible because it is 
superimposed on the original data.
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DISCUSSION
This study describes the development of a GFS algorithm, 
which is an artificially intelligent system, capable of predict-
ing time-domain dynamic physiological data. The resulting 
OFS predicted the complex behavior of isometric contrac-
tions of isolated arteries with an accuracy level beyond 
what, to our knowledge, has been shown with alternative 
mathematical modeling methods. We have shown that 
OFSs could be useful for prediction of the behavior of com-
plex physiological parameters and thereby can objectively 
assist with clustering or classification tasks. This method 
could therefore be useful in assessing the effect of drug 
intervention or perturbation of time-domain physiological 
parameters.
GFS can be designed in various ways depending on the 
purpose of the study and whether previous knowledge of 
the system is available or not.16,17 In this study, we assumed 
that there is no precise knowledge about the contractile 
behavior of an isolated artery, which can form the basis 
for an expert-designed fuzzy logic system or mechanis-
tic model. Hence, a GA was used to randomly generate 
parameters of FSs, which were then coded as sequences 
of genes, in analogy with biological genetic principles.18 
Briefly, individuals in a population of fuzzy systems were 
tested for their ability to predict a training set of physiologi-
cal data and individuals survived, based on precision of the 
prediction (fitness). Several strategies were introduced with 
the purpose of improving the performance of GFSs. It was 
shown that this process was essential because data sets 
were very dynamic, noncyclic, and complex (Figure 1). 
Strategies in which type and weight of membership func-
tions and the generation of membership function variables 
were optimized (strategies 1 and 2) improved the adaptivity 
of GFSs to the dynamic data dramatically (Figure 3a–c). 
Nevertheless, because the search space is multidimen-
sional and multimodal, it appeared likely that the GFS was 
trapped within a bad local minimum of the search space. 
This situation was circumvented by increasing population 
diversity (strategy 3). Although this strategy improved pre-
dictions, searching in some runs preconverged at better 
local minima. Moreover, random replacement of individu-
als in a population increased the probability of escaping 
local minima. When strategies 1–3 were implemented, the 
predictions at the top and the bottom were still suboptimal 
(Figure 4a). Strategy 4 addressed this problem by extend-
ing the fuzzy set variable ranges and changing the defuzzi-
fication method (Figure 4b). It can be concluded that the 
additional strategies prevented premature optimization of 
the GA.19–21
Generally, GFSs are capable of finding an OFS that fits the 
data set well. The advantage is that GFSs are hypothesis free 
and therefore they do not require assumptions with regard to 
the biological system that is being evaluated, which is the 
case for deterministic mechanism–based models such as 
ordinary differential equations. Furthermore, GFSs can learn 
information from a real dynamic complex system. Neural net-
works or genetic neural networks could likewise be used to 
learn dynamic data.22 However, neural networks behave as 
a black box, whereas fuzzy systems provide a description 
of the data by their rule and knowledge base, offering an 
advantage as compared with neural network approaches. 
Although GFSs seem powerful in modeling, there are some 
drawbacks that should be taken into account. First, as men-
tioned earlier, the behavior of the GA is unknown and the 
optimization could become trapped in local minima when 
the search space is highly dimensional, multimodal, or dis-
crete.23 The size of the data set for training and the length 
of the chromosome describing the fuzzy system proportion-
ally increase the complexity of the search space. Therefore, 
second, GA may be computationally intensive in case the 
structure of the GFS is large and complicated. Finally, many 
parameters, such as population size, crossover rate, muta-
tion rate, range for fuzzy sets, and number of fuzzy rules, 
which control the GFS could affect the results. Any of these 
might affect the outcome in an unpredictable and nonlinear 
fashion and it may be a challenge finding the best param-
eters. This problem could be addressed by implementing 
fuzzy systems, GA, or other optimization methods, finding 
optimal parameter values.24 However, this complicates com-
putation further.
The use of GFSs in pharmacological studies
Behavior of a biological system, e.g., as a result of disease 
progression or as effect in response to therapy, can be moni-
tored by measuring surrogate end points such as key physi-
ological time series responses. Analyzing these responses 
and interpreting their consequent or causative action within 
the biological system can be very challenging due to the 
Table 1 Average fitness values of OFSs with increasing number of inputs
Protocol 1 Protocol 2
BV1 BV2 BV3 BV4 BV5 BV6 BV7 BV8
OFS1 0.3911 (1) 0.3961 (3) 0.3859 0.3459 (−10) 0.4870 (26) 0.5331 (38) 0.4597 (19) 0.5443 (41)
OFS2 0.4369 (62) 0.2841 (6) 0.2689 0.3153 (17) 0.3973 (48) 0.6562 (144) 1.0092 (275) 1.2236 (355)
OFS3 1.1628 (179) 0.4886 (17) 0.4166 0.4690 (3) 1.2680 (204) 0.5382 (29) 0.5885 (41) 0.6491 (56)
OFS4 1.8900 (696) 0.3491 (47) 0.2373 0.3713 (56) 0.5887 (149) 1.3367 (464) 1.1468 (384) 0.4332 (83)
The table shows the impact of changes in GFS design with respect to the number of inputs on the performance of OFS. OFS1(OFS(222)) uses error and 
change of error as inputs; OFS2 (OFS(2222)) adds one more input, average of integration of all previous errors from current time point; OFS3(OFS(2222)) 
adds one more input, average of integration of five previous neighboring errors from current time point; OFS4 (OFS(222222)) adds three more inputs, time 
points before current time point t, such as t − 4, t − 7, and t − 10. Shown are average fitness (fitness value/length of data given in ‰) and percentage difference 
from the training data fitness (numbers in brackets) for each respective OFS. This percentage difference does not reflect error, but a large difference of fitness 
values between training and test data indicates a more specific OFS for the training set. Differences in fitness can therefore be indicative of differences in 
dynamic behavior of the original data.
GFS, genetic fuzzy system; OFS, optimized fuzzy system.
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dynamic nature and inherent adaptive properties of the bio-
logical system toward perturbations. As suggested previously 
by others,25 fuzzy systems may offer an attractive method to 
describe these complex systems. The final result of an OFS 
demonstrates that fuzzy control systems can adapt to the 
dynamic changes of, as shown in this example, contractile 
behavior of isolated arteries exposed to external perturba-
tions and can identify differences in effect patterns that are 
not detectable using conventional analysis.
More importantly, the results shown in Table 1 and Fig-
ure 6 demonstrate that OFSs, on the basis of their fitness 
levels, could distinguish between behaviors from different 
experimental protocols and, therefore, could be applied for 
advanced data analysis, such as clustering and classifica-
tion. In cases where conventional statistical methods may 
fall short, e.g., during preclinical safety assessment of new 
drugs, OFSs could contribute with objective evaluation of 
results.
Figure 6 Comparison of OFSs  with conventional analysis of data. (a) Representative recordings of cumulative concentration–response curves 
constructed by the addition of increasing concentrations of noradrenaline to isolated arteries that had been mounted in a wire myograph. Small 
rat mesenteric arteries in Group A had been freshly isolated, whereas those in Group B had been subjected to tissue culture for a period of 
24 h (see Supplementary Data for details). (b) These recordings were analyzed by extracting maximum responses (left) or by averaging all 
data points per concentration of noradrenaline (right) and expressed as a percentage of contractions induced by a depolarizing high potassium 
solution. Calculation of noradrenaline potency (−LogEC50) and maximal effects (Emax) using nonlinear logistic regression did not show significant 
differences between groups (for b (left panel): noradrenaline − LogEC50 6.06 ± 0.05 and 6.12 ± 0.05; Emax 129.8 ± 5.4% and 131.5 ± 5.5%, for 
Groups A and B, respectively; for right panel: noradrenaline − LogEC50 5.96 ± 0.05 and 5.96 ± 0.05; Emax 147.9 ± 6.1% and 135.3 ± 6.2%, for Groups 
A and B, respectively). (c) fitness values for all artery recordings (per group) that were obtained by running an OFS with five inputs and one 
output, which was trained on a random artery of either Group A (left panel) or Group B (right panel). The difference between fitness values for 
these groups was highly significant, indicated by the asterisk (unpaired t-test, P = 0.0001 and P = 0.0003, respectively, for left and right panels).
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Finally, future research could address whether the rules 
in OFS may form the basis for mechanistic mathematical 
modeling of complex high-level physiological parameters in 
biological systems. Some studies hypothesize that biological 
systems are managed by rules organized in a hierarchical 
structure.26 Fuzzy systems may provide a means to generate 
these rules by learning from experimental data. Furthermore, 
OFSs could be applied in other rule-based modeling, such as 
agent-based modeling.27
Future perspective
The herein-presented results show that OFSs can predict 
experimental data accurately. However, the OFSs described 
in this study are type 1 fuzzy systems, and these do not 
handle uncertainty in experimental data optimally. Type 2 
fuzzy systems could solve this problem.28–30 Another short-
coming in the current approach could be that OFSs predict 
one step ahead, although with high accuracy. Hence, long-
term prediction or increasing memory of mode in time could 
be another feature of this approach because this would be 
particularly useful in predicting pharmacodynamics of drugs. 
There are several examples of long-term prediction,22,31 and 
the principles behind these methods could be implemented 
in future GFS models.
Taken together, hypothesis-free GFSs appear very effec-
tive in predicting complex time-domain physiological data 
and can be used in identification, clustering, or classification 
problems. As such, OFSs could aid in identifying minute but 
important differences in disease- or drug-induced changes in 
pivotal physiological parameters, which may not be possible 
with conventional analysis methods.
MeTHODS
Data sets
Different archived data sets of isometric tension develop-
ment of isolated small femoral or mesenteric arteries (of 
male rats) mounted in a wire myograph were used. One set 
(data set 1) was used for development of the GFS, and the 
other (data set 2) for testing the OFS. Arteries had been 
normalized to their individual optimal diameter for active 
force development as previously described.32 Tension data 
were collected using Myodaq (DMT, Aarhus, Denmark). 
The data range encompasses a baseline resting tension 
of fully relaxed arteries and maximal contractile responses, 
not necessarily the absolute maximum contractile response 
obtainable in these preparations. Apparent transmural pres-
sure was calculated using the Laplace relation.32 The data 
sets represent an evolution of transmural pressure of iso-
lated resistance-sized arteries over time. Furthermore, 
original data were preprocessed and normalized (see Sup-
plementary Data). Data set 1 consisted of two experimen-
tal protocols containing four arteries each. These protocols 
consisted of consecutive single concentrations or cumulative 
concentration–response curves to various vasoactive sub-
stances (see Supplementary Data). Data set 2 consisted 
of two groups, one containing recordings of norepinephrine 
cumulative concentration–response curves constructed in 
freshly isolated rat small mesenteric arteries, and the other 
containing recordings of the same protocol in arteries that 
had been kept in tissue culture medium for 24 h. Concentra-
tion–response curves were conventionally analyzed either 
by measuring maximum responses per agonist concentra-
tion or by averaging all data points per agonist concentra-
tion, taking into account differences in concentration time 
intervals (Myodata, DMT A/S, Aarhus, Denmark). These 
data were further analyzed by four-parameter nonlinear 
logistic regression (Prism, Graphpad, La Jolla, CA), yielding 
norepinephrine potency (half-maximal effective concentra-
tion or EC50) and maximum responses. These values were 
compared using the F-test (Prism, Graphpad, La Yolla, CA). 
In addition, OFS(222222) with five inputs and one output, 
was trained on whole recordings of a random artery from 
either Group A or Group B and fitness values of these OFSs 
for all arteries in both groups were obtained. Fitness values 
of groups were compared using the unpaired t-test.
Genetic fuzzy system
Learning and predicting artery contractile behavior using 
GFS: Autoregulation and feedback are pivotal in complex 
biological systems, from the molecular level33 to the organ 
and system levels.34 Autoregulation can maintain a dynamic 
equilibrium of biological systems even after a sudden or 
long-time disturbance. Therefore, in our assumption, arter-
ies autoregulate their dimensions around an optimal set 
point or attractor following perturbations by physical or 
chemical interventions, and this control can be simulated by 
a fuzzy control system. In this study, the symbol GFS(n1n2…
nk)(Genetic Fuzzy System) and training result OFS(n1n2…
nk) (Optimized Fuzzy System) are used to illustrate the 
structure of fuzzy systems. n1n2…nk means the number of 
fuzzy sets for inputs or outputs. Here, only one output is 
used; therefore, nk designates output and all previous num-
bers’ inputs. The first input is the change of error (CE): CE 
= P2 − P1; and the second is error (E): E = S − P1, accord-
ing to Ying.35 P1 denotes current pressure, P2 denotes the 
next pressure, and S indicates the set point. Moreover, to 
test the specificity of the fuzzy system, GFS(n1n2n3n4) and 
GFS(n1n2n3n4n5n6) with additional inputs were implemented (these are described in the Supplementary Data). In all 
implementations, the set point, range of fuzzy sets, mem-
bership functions, and rules were unknown and needed to 
be optimized with training data. Furthermore, the search 
space for optimization was limited by defining the range for 
each unknown parameter according to the training data18 
and by experience.
Strategies improving performance: The overall design of 
the GFS was derived from the study of Shi et al.18 and is 
further described in the Supplementary Data. To improve fit-
ness, four strategies were applied to this algorithm.
Strategy 1: Assigning weight to each rule and increasing 
number of membership functions.
In theory, rules are not equally predicting the output. To 
address this difference between rules, a rule weight was 
assigned between 0 and 1. Twelve membership functions 
(Supplementary Figure S1) were used to ascertain optimal 
conditions for the fuzzy system to fit the training data. Differ-
ent functions may have a different number of relevant param-
eters (two to four parameters). Therefore, to ensure that all 
individuals in the same population had the same length, all 
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membership functions were assigned four parameters even 
though one or two of the four parameters may be consid-
ered nonsense data. The first parameter is the start point 
of the fuzzy set and the fourth is the end point of the same 
fuzzy set. Furthermore, all parameters were arranged in an 
ascending order.
Strategy 2: Random generation of membership function 
parameters and sorting in ascending order. 
The varying range of each fuzzy set was defined in the 
same way as previously described.18 Each membership func-
tion had four parameters, and these generated randomly 
within the range of the fuzzy set. Then, the lowest and the 
highest determined the fuzzy set range. Ultimately, each 
fuzzy set consisted of five parameters, four randomly gen-
erated parameters, and a number defining its membership 
function.
Strategy 3: Increasing population diversity by randomly 
replacing similar individuals. 
Although GAs are powerful in global searching, there is a 
risk that they become trapped in a local minimum because 
of the complex search space. Increasing the diversity of the 
population reduces this risk. First, one of two or more indi-
viduals who had the same fuzzy sets and rules with similar or 
different weights for rules, survived. Then, some individuals 
died randomly, except elite individuals, who had the best fit-
ness. In order to maintain the size of the population constant, 
new individuals were generated randomly.
Strategy 4: Extending fuzzy set variable ranges and chang-
ing defuzzification. 
In this approach, if the first and last fuzzy sets were 
defined according to the exact range of the data set, 
some membership functions, e.g., Supplementary Fig-
ure S1d–j would be mostly ignored. As a result, prediction 
of data points at the extremes of the output would not be 
optimal. To circumvent this, extension of the first and last 
fuzzy sets with two steps18 into directions beyond the range 
of inputs or outputs was expected to yield better predic-
tions. In this way, the minimum or maximum value would be 
at the center of the fuzzy set and could be predicted using 
the centroid method in a fuzzy system. To further enhance 
the prediction of data points at the extremes of outputs, 
a new defuzzification method was introduced by summa-
rizing the results from different defuzzification methods 
available in Matlab. The reason is that the results from 
these methods vary over a wide range and a compromise 
between these methods was expected to better predict 
results. Finally, multiple threads executed in parallel using 
the Matlab “Parallel computing toolbox,” enhancing speed 
of computation.
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